AVR 0.19% $18.00 anteris technologies ltd

News: AHZ Admedus Says Cardiocel 3D And Vascucel Receives European Regulatory Approval, page-437

  1. 1,533 Posts.
    lightbulb Created with Sketch. 300
    I agree our governments (both sides ) really need to keep their eyes on the ball as to what’s happening with Aust biotecs . Realisticaly in Aust Medicare would pay for this entire operation so why doesn’t the Aust government pay for the trial . I am sure AHZ would only be to happy to supply the TAVR valves for free
 
watchlist Created with Sketch. Add AVR (ASX) to my watchlist
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.